News European biotech leaders say optimism is returning Senior figures in European biopharma think dealmaking and M&A will increase in the region, and could be helped by US policy uncertainties.
News Bayer names Christoph Koenen as its new CMO Bayer has looked internally for its chief medical officer, appointing Christoph Koenen to the post alongside his current clinical development role.
News PhRMA hires ex-House Majority Leader Eric Cantor as its CEO Former Republican lawmaker Eric Cantor has been named as the new CEO of US pharma group PhRMA, replacing long-serving Stephen Ubl.
News Bavarian Nordic has found its new CEO Six months after Paul Chaplin said he was stepping down as CEO of Bavarian Nordic, the Danish biopharma has named Tarja Stenvall to the role.
News Legend Biotech names ex-Novartis exec as CEO Cell therapy developer Legend Biotech has named Ingrid Zhang as its new chief executive, ending its search for new leadership.
News Chiesi fills permanent CEO role with Flagship's Khougazian Chiesi has named Flagship's David Khougazian as its new permanent chief executive, following the departure of Giuseppe Accogli earlier this year.
News Iambic prices its IPO, seeking to raise up to $160m AI-powered drug discovery company Iambic Therapeutics has announced the terms of its Nasdaq IPO, pitching at a valuation of more than $800m.
Digital Sponsored Discover a new era of healthcare panel engagement: Grounded ... A new webinar from Konovo will address some of the critical topics impacting today’s healthcare market research industry.